MLAB logo

Mesa Laboratories, Inc. Stock Price

NasdaqGS:MLAB Community·US$389.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

MLAB Share Price Performance

US$70.60
-43.02 (-37.86%)
US$70.60
-43.02 (-37.86%)
Price US$70.60

MLAB Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Undervalued with moderate growth potential.

0 Risks
3 Rewards

Mesa Laboratories, Inc. Key Details

US$245.3m

Revenue

US$92.8m

Cost of Revenue

US$152.4m

Gross Profit

US$154.0m

Other Expenses

-US$1.6m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.28
62.15%
-0.64%
98.0%
View Full Analysis

About MLAB

Founded
1982
Employees
730
CEO
Gary Owens
WebsiteView website
www.mesalabs.com

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Recent MLAB News & Updates

Mesa Laboratories (NASDAQ:MLAB) Has Announced A Dividend Of $0.16

Nov 07
Mesa Laboratories (NASDAQ:MLAB) Has Announced A Dividend Of $0.16

Recent updates

No updates